Pioneer in phage-based diagnostics

01359 231856

Twitter Youtube Linkedin Envelope
  • Home
  • About
    • About PBD Biotech
    • Leadership
    • Blog
  • Latest
    • Press releases
    • In the news
    • Events
  • Actiphage TB
    • What is Actiphage TB?
    • Unique role in TB testing
    • Supporting test and treat campaigns
    • Clinical studies
  • Lab Support
    • Laboratory Support
    • Solutions for laboratory developed tests
    • Actiphage assay workflow
    • Instructions for use of Actiphage
  • TB Drug Research
    • TB drug research
    • Research Use Only
    • Biomarker for TB prevention
  • Contact
    • Contacting us
    • Partnerships and collaborations
Menu
  • Home
  • About
    • About PBD Biotech
    • Leadership
    • Blog
  • Latest
    • Press releases
    • In the news
    • Events
  • Actiphage TB
    • What is Actiphage TB?
    • Unique role in TB testing
    • Supporting test and treat campaigns
    • Clinical studies
  • Lab Support
    • Laboratory Support
    • Solutions for laboratory developed tests
    • Actiphage assay workflow
    • Instructions for use of Actiphage
  • TB Drug Research
    • TB drug research
    • Research Use Only
    • Biomarker for TB prevention
  • Contact
    • Contacting us
    • Partnerships and collaborations

‘We can #EndTB’ – phage-based diagnostics for TB to be discussed at AACC webinar

Date: 19 April 2023

The role of phage-based laboratory diagnostics in the detection of tuberculosis is to be discussed in a live webinar hosted by the AACC, it has been announced ahead of World TB Day.
AACC webinar phage-based TB diagnostics

Accelerating the preventive drug treatment of people infected with latent tuberculosis (LTBI) is a high priority to eradicate TB disease and a focus of the ‘We Can #EndTB’ campaign.

To achieve this ambitious goal, diagnostic tests are urgently needed to screen latent tuberculosis LTBI and determine who will progress to active TB disease.

Phage-based diagnostics offer the ability to differentiate between active and past infections.

However, a broader understanding of the LTBI diagnostic landscape is needed to support wider implementation of LTBI treatment with new diagnostics.

In this webinar, Dr Pranab Haldar and Dr Tony Hu will discuss the changing paradigm of the spectrum of TB infection, incipient TB, and the progression to active TB.

They will review the epidemiology of TB and limitations of current tests that look at host response. They will also explain how, by enabling direct detection of the pathogen in the blood, phage-based diagnostics provide the opportunity to determine incipient/subclinical disease, as demonstrated in recent clinical trials.

The webinar ‘Phage-Based Laboratory Diagnostics Role in the Detection of Tuberculosis’ will be hosted by the American Association of Clinical Chemistry (AACC) on 19 April 2023 from 12 – 1 PM (Eastern Time) (5 – 6 PM BST).

It will feature:

  • Dr Pranabashis Haldar, Clinical Senior Lecturer and Honorary Consultant Physician in Respiratory Medicine for National Institute for Health Research Respiratory Biomedical Research Centre at University of Leicester, UK.
  • Dr Tony Hu, Weatherhead Presidential Chair in Biotechnology Innovation Professor of Biochemistry and Molecular Biology, Microbiology, and Biomedical Engineering at School of Medicine, Tulane University, USA.

There will be an opportunity for live Q&A with the speakers.

To participate in the webinar visit https://www.aacc.org/education/all-webinars

More about phage-based diagnostics for TB detection.

Dr Pranab Haldar
Dr Pranab Haldar
Dr Tony Hu, Tulane University
Dr Tony Hu, Tulane University [image from nanodetection.org]
Share:
  • Events, HUMAN TB, Latest

Related posts

Loading...

Join PBD Biotech at the 2023 AACC Clinical Lab Expo, Booth #4578, to learn more about Actiphage

May 26, 2023
Without treatment 1 in 10 people with latent TB will progress to active TB but how can they be identified?

Join PBD Biotech at the 2023 AACC Clinical Lab Expo, Booth #4578, to learn more about Actiphage

May 26, 2023
Without treatment 1 in 10 people with latent TB will progress to active TB but how can they be identified?
pan North West of England’s Health and Life Sciences Cluster fight-against-infectious-disease

Phage-based diagnostics and the fight against infectious disease

May 22, 2023
PBD Biotech to speak at Liverpool School of Tropical Medicine anniversary celebrations
pan North West of England’s Health and Life Sciences Cluster fight-against-infectious-disease

Phage-based diagnostics and the fight against infectious disease

May 22, 2023
PBD Biotech to speak at Liverpool School of Tropical Medicine anniversary celebrations
Actiphage TB diagnostic releases bacterial DNA for qPCR

16 May 2023

New Centre for Phage Research features Actiphage within Innovation Showcase

May 12, 2023
The UK’s first Centre for Phage Research is being officially launched on 16th May and featured in the UK KTN UK Phage Innovation Showcase will be Actiphage®, a phage-based molecular diagnostic for tuberculosis.
Actiphage TB diagnostic releases bacterial DNA for qPCR

16 May 2023

New Centre for Phage Research features Actiphage within Innovation Showcase

May 12, 2023
The UK’s first Centre for Phage Research is being officially launched on 16th May and featured in the UK KTN...
AACC Conference 2023 PBD booth 4578

23 - 27 July 2023

AACC Annual Scientific Meeting – Actiphage on booth 4578

April 14, 2023
The 2023 AACC Annual Scientific Meeting & Clinical Lab Expo will be an opportunity to find out more about phage-based diagnostics.
AACC Conference 2023 PBD booth 4578

23 - 27 July 2023

AACC Annual Scientific Meeting – Actiphage on booth 4578

April 14, 2023
The 2023 AACC Annual Scientific Meeting & Clinical Lab Expo will be an opportunity to find out more about phage-based...
1 2 … 9 Next »

developers of phage-based diagnostics

Contact Us
BIVDA member 2023

Registered Company Address
Grosvenor St Paul’s
Grosvenor House
11 St Paul’s Square
Birmingham
B3 1RB
United Kingdom

T: 01359 231856
info@pbdbio.com

Privacy and cookies policy

© 2022 PBD Biotech Ltd

design: out of house

  • Follow Us!